secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001493152-24-044124
Event type: earnings
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma Q3 2024 earnings call held; no financial details in 8-K
----------------------------------------------------------------------

- Conference call and live webinar occurred on November 7, 2024 for Q3 results.
- Presentation covering financial and operating results furnished as Exhibit 99.1.
- No specific revenue, EPS, or guidance figures were disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315224044124/0001493152-24-044124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315224044124/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-044124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer